Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits
Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system
“The device takes variability out of the procedure by giving the operator full control while automating ramp-up and back-up algorithms," according to a clinician who used the new technology. "The TAVR procedure is simplified, reducing physician and staff workload."

Trump administration to end funding for COVID-19 testing sites

The Trump administration is planning to cut funding for 13 drive-thru COVID-19 testing sites at a time when cases and deaths in the U.S. continue to skyrocket, Politico reported.

Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

Sapien 3 TAVR outcomes comparable to surgery after 5 years

Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

A fresh look at what does (age, diabetes) and does not (hypertension) predict death from COVID-19

A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients.

Catheter-based heart failure treatment gains breakthrough device designation

preCARDIA announced that its catheter-based system for acutely decompensated heart failure has received the FDA’s breakthrough device designation.

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

Cardiologists shed new light on COVID-19 and cardiac arrhythmias

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

Protein boosts heart attack recovery, could be a game-changer for patients

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

Clinical

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits

AI-based coronary plaque evaluations highlight elevated heart risks in women

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

Cardiologist-founded startup announces FDA clearance, first uses of new TAVR pacing system